LBRX Operating Cash Flow Per Share from 2010 to 2026

LBRX Stock   23.82  0.04  0.17%   
LB Pharmaceuticals Operating Cash Flow Per Share yearly trend continues to be fairly stable with very little volatility. Operating Cash Flow Per Share is likely to outpace its year average in 2026. Operating Cash Flow Per Share is a measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis. View All Fundamentals
 
Operating Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
(17.24)
Current Value
(16.37)
Quarterly Volatility
6.03579426
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check LB Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LB Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 800, Net Interest Income of 2.1 M or Interest Income of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. LBRX financial statements analysis is a perfect complement when working with LB Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with LBRX Stock
Check out the analysis of LB Pharmaceuticals Correlation against competitors.
The evolution of Operating Cash Flow Per Share for LB Pharmaceuticals Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how LB Pharmaceuticals compares to historical norms and industry peers.

Latest LB Pharmaceuticals' Operating Cash Flow Per Share Growth Pattern

Below is the plot of the Operating Cash Flow Per Share of LB Pharmaceuticals Common over the last few years. It is a measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis. LB Pharmaceuticals' Operating Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LB Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Operating Cash Flow Per Share10 Years Trend
Slightly volatile
   Operating Cash Flow Per Share   
       Timeline  

LBRX Operating Cash Flow Per Share Regression Statistics

Arithmetic Mean(3.65)
Coefficient Of Variation(165.42)
Mean Deviation4.43
Median(0.77)
Standard Deviation6.04
Sample Variance36.43
Range16.4695
R-Value(0.69)
Mean Square Error20.12
R-Squared0.48
Significance0
Slope(0.83)
Total Sum of Squares582.89

LBRX Operating Cash Flow Per Share History

2026 -16.37
2025 -17.24
2024 -14.99
2023 -3.42

About LB Pharmaceuticals Financial Statements

LB Pharmaceuticals investors use historical fundamental indicators, such as LB Pharmaceuticals' Operating Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LB Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cash Flow Per Share(17.24)(16.37)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LBRX Stock Analysis

When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.